Cai G (2020).Tobacco-use disparity in gene expression of ACE2, the receptor of 2019-nCov COVID-19 y enfermedades respiratorias / 25 de Abril del 2020 Read more
ATS International Task Force (03/04/2020). COVID‐19 Interim Guidance on Management Pending Empirical. Tratamientos e interacciones farmacológicas / 25 de Abril del 2020 Read more
Amgalan A (2020). Letter to de Editor ExPloring possible mechanisms for COVID-19 induced thrombocytopenia Unanswered Questions COVID-19 y enfermedades cardiovasculares / 25 de Abril del 2020 Read more
Yin S. et al. (2020). Diference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2 COVID-19 y enfermedades cardiovasculares / 25 de Abril del 2020 Read more
GOLD COVID-19. Recomendaciones EPOC COVID-19 y enfermedades respiratorias / 25 de Abril del 2020 Read more
Wu Y et al. (2020). Nervous system involvement after infection with COVID-19 and other coronaviruses COVID-19 y enfermedades neurológicas / 24 de Abril del 2020 Read more
¿Qué sabemos de la vacuna frente al COVID-19? Para profesionales Publicaciones SEFAC Publicaciones SEFAC: materiales disponibles para el socio / 24 de Abril del 2020 Read more
Wu et al. (2020). Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention Epidemiología / 24 de Abril del 2020 Read more
Singhal, T (2020). A Review of Coronavirus Disease-2019 (COVID-19) Sintomatología / 24 de Abril del 2020 Read more
Presentación de la sesión 'Actualización y avances en COVID-19 y farmacia comunitaria' Publicaciones SEFAC Publicaciones SEFAC: materiales disponibles para el socio / 24 de Abril del 2020 Read more